Medicenna Therapeutics Corp.
MDNA.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.01M | 4.49M | 7.74M | 11.31M | 15.00M |
| Total Receivables | 1.07M | 966.70K | 1.07M | 906.70K | 859.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 643.90K | 517.10K | 609.00K | 618.10K | 694.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.72M | 5.97M | 9.42M | 12.83M | 16.55M |
|
|
|||||
| Total Current Assets | 5.72M | 5.97M | 9.42M | 12.83M | 16.55M |
| Net Property, Plant & Equipment | 52.80K | 64.60K | 75.10K | 86.20K | 104.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 31.70K | 33.80K | 35.00K | 35.20K | 36.70K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 5.81M | 6.07M | 9.53M | 12.95M | 16.70M |
|
|
|||||
| Total Accounts Payable | 4.31M | 3.48M | 3.10M | 2.62M | 2.34M |
| Total Accrued Expenses | 207.60K | 396.40K | 369.00K | 539.20K | 973.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 50.00K | 46.70K | 47.40K | 44.50K | 42.50K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.57M | 3.93M | 3.52M | 3.20M | 3.35M |
|
|
|||||
| Total Current Liabilities | 4.57M | 3.93M | 3.52M | 3.20M | 3.35M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 23.20K | 38.80K | 51.10K | 62.50K | 76.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 37.30K | 325.30K | 1.43M | 2.34M | 2.53M |
| Total Liabilities | 4.63M | 4.29M | 5.00M | 5.60M | 5.96M |
|
|
|||||
| Common Stock & APIC | 100.79M | 99.82M | 101.07M | 99.26M | 101.03M |
| Retained Earnings | -99.75M | -98.15M | -96.58M | -91.94M | -90.32M |
| Treasury Stock & Other | 145.70K | 113.50K | 39.40K | 36.60K | 25.70K |
| Total Common Equity | 1.18M | 1.78M | 4.53M | 7.35M | 10.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.18M | 1.78M | 4.53M | 7.35M | 10.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.18M | 1.78M | 4.53M | 7.35M | 10.74M |
|
|
|||||